ABOUT 483a OBSERVATION IN PHARMACEUTICAL COMPANY
Sure, here is an explanation of 483a observation by the USFDA in a pharmaceutical company, presented in easy Hinglish bullet points:
USFDA ki ek team pharmaceutical companies ko inspect karti hai, agar unko koi kami ya galat kaam nazar aata hai, toh woh 483a observation naam ki ek report banati hai.
Is report mein FDA ki team ne company ke kaam mein ki gayi kamiyan ya galatiyon ko likha hota hai, jismein se kuch kamiyan behad serious hoti hai.
Is report mein company ke kaam ke kuch aise tukde bhi hote hai, jinmein koi kami nahi hai, par overall dekha jaye toh unki performance kamzor hoti hai.
Is report mein company ko bataya jata hai ki kis area mein unka kaam FDA ke rules aur regulations ke khilaaf hai.
Is report mein company ko woh bhi bataya jata hai ki woh kya karein jisse woh galati ko theek kar sakein.
Company ko ek time limit diya jata hai, jismein woh apni galti ko sudhaar ke FDA ko report karna hota hai.
Agar company apni kamiyon ko theek nahi karti hai, toh FDA aur bhi sakht kadam utha sakti hai jaise warning letter, fine ya product recall.
Isliye company ko turant apni galti ko sudhaarne mein jaldi karna chahiye, taki woh FDA ke rules aur regulations ko follow kar sakein aur unke products ka quality maintain ho sakein.
Thank you for visiting, see you again 🙏
Comments
Post a Comment